Status:
COMPLETED
Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Quality of Life in Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
Since subjective well-being and quality of life (QoL) are increasingly being recognized as important treatment outcomes in patients with schizophrenia (Hofer et al., 2004; Becker et al., 2005), the ai...
Eligibility Criteria
Inclusion
- Adult schizophrenia patients
- Inclusion according to Summary of product characteristics
Exclusion
- Diagnosis other than schizophrenia
- Patients for which Seroquel XR is not registered (pregnant women, children and adolescents…)
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00934726
Start Date
July 1 2009
End Date
October 1 2010
Last Update
September 23 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.